(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.\u0010\u0010GUEST:\u0010HEALTHCARE IN FOCUS: Liz Krutoholow, Specialty Pharma and Biotech Analyst for Bloomberg Intelligence, on Mylan selling a generic version of EpiPen to quell outcry over pricing.

Lyft Earnings Miss Estimates After Global Expansion Push
25:56

Wall Street Poised for Bonus Increases in ‘Year of the Bank’
26:24

AMD Soars as AI Demand Fuels Better-Than-Expected Sales Outlook
20:33